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Background: Previously, we reported that prenatal exposures to polycyclic aromatic hydrocar-
bons (PAH) and postnatal environmental tobacco smoke (ETS) in combination were associated
with respiratory symptoms at ages 1 and 2 years. Here, we hypothesized that children exposed
to both prenatal PAH and ETS may be at greater risk of asthma and seroatopy at ages 5e6
years, after controlling for current pollution exposure.
Methods: Prenatal PAH exposure was measured by personal air monitoring over 48 h. ETS expo-
sure, respiratory symptoms and asthma at ages 5e6 years were assessed through question-
naire. Immunoglobulin (Ig) E was measured by Immunocap.questionnaire; CCCEH, Columbia Center for Children’s environmental health; DEP, diesel exhaust
nvironmental tobacco smoke; ISAAC, international study of asthma and allergies in childhood; NYC,
tic hydrocarbons; PM, particulate matter; PUF, polyurethane foam; ROS, reactive oxygen species.
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870 M.J. Rosa et al.Results: A significant interaction between prenatal PAH and prenatal (but not postnatal) ETS
exposure on asthma (p < 0.05), but not IgE, was detected. Among children exposed to prenatal
ETS, a positive nonsignificant association was found between prenatal PAH exposure and
asthma (OR 1.96, 95% CI [0.95e4.05]). Among children without exposure to prenatal ETS,
a negative nonsignificant association was found between prenatal PAH exposure and asthma
(OR 0.65, 95% CI [0.41e1.01]). Prenatal PAH exposure was not associated with asthma or IgE
at age 5e6 years.
Conclusions: Combined prenatal exposure to PAH and ETS appears to be associated with
asthma but not seroatopy at age 5e6. Exposure to PAH alone does not appear associated with
either asthma or seroatopy at age 5e6 years. Discerning the differential effects between ETS
exposed and ETS nonexposed children requires further study.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Exposure to diesel exhaust particles (DEP) has been asso-
ciated with greater morbidity and mortality due to respi-
ratory illnesses.1e5 DEP consists of a carbonaceous core
onto which metals and other chemicals such as polycyclic
aromatic hydrocarbons (PAHs), heterocyclics, quinones,
aldehydes, and aliphatic hydrocarbons are adsorbed.6 The
effects of these individual components on respiratory
illness remain understudied. However, studies suggest that
exposure to PAH in particular, emitted from traffic sources,
cigarette smoking, cooking and space heating, may be
associated with the development and exacerbation of
asthma and seroatopy.7,8 Previously, our group at the
Columbia Center for Children’s Environmental Health
(CCCEH) reported significant interactions between PAH
exposure measured prenatally and early postnatal exposure
to environmental tobacco smoke (ETS) on the outcomes of
cough and wheeze at age 1 year and difficulty breathing
and probable asthma at age 2 years in children in NYC.9
Similar results were reported in Poland, where PAH levels
were several times higher than the ones measured in NYC.10
Despite these reports, the importance of prenatal PAH
exposure, independently and in association with ETS, on
persistent wheeze and asthma still needs to be ascertained.
Earlywheeze and respiratory symptomsmaybe transient and
not necessarily be associated with persistent wheeze or
asthma at later ages.11 Associations of prenatal PAH and ETS
exposure with asthma also would need to consider the effect
of later postnatal exposures thatmay correlatewith prenatal
levels. We hypothesized that children exposed to higher
levels of PAH prenatally combined with ETS (either prenatal
or postnatal) may be at greater risk of wheeze, asthma and
seroatopy at ages 5e6 years, even after controlling for
current exposure to PAH and ETS. Our strategy, using
a longitudinal design based within the CCCEH birth cohort,
was to examine the association of repeat measures of PAH
and ETS exposure with symptoms ascertained when the
children reached 5 through 6 years of age.
Methods
Study population
Briefly, 725 nonsmoking, healthy women who self-identified
as Dominican ethnicity or African American race and livingin Northern Manhattan or the South Bronx were enrolled
during pregnancy and their children followed pro-
spectively.12e14 Questionnaires were administered prena-
tally, and at ages one, two, three and 5e6 years. Data were
analyzed for those children (n Z 290) for whom airborne
PAH measures at two time points (prenatal, age 5e6 years)
and complete questionnaire data were available. The study
was approved by the Columbia University Institutional
Review Board.
PAH exposure
During the prenatal period, personal air monitoring over
48 h was conducted during the third trimester as
described.9 Personal pumps ran continuously and collected
particles up to 2.5 mm in diameter on a quartz microfiber
filter and gas phase PAH were collected on a polyurethane
foam (PUF) sampler. At age 5 through 6, a two-week home-
based indoor monitoring was used to determine PAH expo-
sure as described.15 Briefly, monitors were set up in the
room where the child spent most of his/her time at a height
of about 1.2 m and at least 0.3 m from the walls. Particles
and gas phase PAH collected from the first two-week
monitoring period were extracted together. Filters from
both time points were analyzed for 9 PAH compounds: benz
(a)anthracene, benzo(b)fluoranthene, benzo(k)fluo-
ranthene, benzo(ghi)perylene, benzo(a)pyrene, chrysene/
isocrysene, dibenz(a,h)anthracene, indeno(1,2,3) pyrene
and pyrene at the Southwest Research Institute. Anthra-
cene-d10 and p-terphenyl-d14 were used as surrogate stan-
dards for recovery and chrysen-d12 and perylene-d12 were
used as internal standards for quantification. Data were
flagged if any monitoring problems occurred (i.e. power
outages, flow rate changes, tube disconnection, pump
failure, etc) and additional analysis flags were assigned to
PAH compounds below the limit of detection (LOD),
elevated peaks due to presence of an interference peak, or
questionable peaks. Flagged samples were excluded from
statistical analysis based on a previously established
protocol.15
ETS exposure
Prenatal ETS exposure among children of mothers who did
not smoke during pregnancy was defined as the report of
any smoker in the home during pregnancy. Postnatal ETS
Table 1 Demographics of cohort subset included in these
analyses.
Male sex, n (%) 130/290 (44.8)
Ethnicity/Race
Dominican, n (%) 178/290 (61.4)
African American, n (%) 112/290 (38.6)
Mother not completed high
school, n (%)
109/290 (37.6)
Any report of maternal
asthma, n (%)
75/290 (25.9)
Child current wheeze, n (%) 98/290 (33.8)
Doctor diagnosed asthma, n (%) 98/290 (33.8)
Nighttime wheeze, n (%) 68/290 (23.4)
Asthma medication use, n (%) 96/290 (33.1)
ER visits, n (%) 84/290 (29.0)
Child total IgE 50 IU/mL 91/201 (45.3)
At least one SIgE 0.35 IU/mL 63/208 (30.3)
Prenatal ETS 93/290 (33.8)
Postnatal ETS 123/290 (42.4)
Prenatal PAH median(25the75th) 2.28 (1.43e3.64)
Postnatal PAH median(25the75th) 1.33 (0.81e2.24)
Ethnicity/race, maternal education and history of maternal
asthma determined at the time of mother’s enrollment. Doctor
diagnosed asthma is defined as maternal report of doctor’s
diagnosis of asthma at ages 5 or 6 years. Current wheeze is
defined as wheeze reported by mother/caretaker in the past 12
months using ISAAC questionnaire at age 5 or 6. Asthma medi-
cation use defined as report of asthma medication use in the
past 12 months by BRQ at age 5 or 6 years. Emergency room
visits are defined as at least one visit to the ER in the past 12
months due to breathing problems by BRQ at age 5 or 6 years.
Nighttime wheeze are defined as sleep disturbed by wheeze at
least one time a week in the past 12 months by ISAAC ques-
tionnaire at age 5 or 6 years.
Prenatal exposure to polycyclic aromatic hydrocarbons 871was defined as the report of any smoking household
member when the child was aged 6 months, 1, 2, 3 or 5
years. Plasma cotinine was measured in cord blood and at
ages 2, 3 and 5 years at the Center for Disease Control and
Prevention and used to validate data obtained from ques-
tionnaire. Chi-square tests for trend were run to validate
the association between plasma cotinine levels from cord
blood or ages 2 and 3 years (insufficient sample size for age
5) and report of ETS in the home at the corresponding age.
Analyses were repeated examining report of ETS in the
home or at work. Cotinine levels were split into quartiles
and the lowest quartile included those cotinine levels
below limit of detection (LOD). The association between
ETS exposure and cotinine levels was highly significant at all
ages (c2 for trend for prenatal ETS, ETS at age 2 years, ETS
at age 3 years, p < 0.001 for each). Similar results were
found when ETS exposure was defined as either report of
smoker at home or at work for prenatal ETS, and report of
a smoker at home or outside smoke exposure for postnatal
ETS at ages 2 and 3 years (data not shown).
Questionnaires and IgE
The Brief Respiratory Questionnaires (BRQ), validated in
a similar local urban population,16 and the International
Study of Asthma and Allergies in Childhood questionnaires
(ISAAC), validated internationally,17 were administered at
both ages 5 and 6 years. The BRQ was used to assess report
of doctor diagnosis of asthma, emergency room visits due to
breathing problems, and use of asthma medications in the
past 12 months at either age. The ISAAC questionnaire was
used to assess current wheeze, defined as any report of
wheeze in the past 12 months, and nighttime wheeze,
defined as sleep disturbed by wheeze at least one night
a week in the past 12 months at either age 5 or 6 years.
Total serum IgE and specific IgE to cat, mouse, Derma-
tophagoides farinae and German cockroach at age 5 years
were measured in duplicate using Immunocap (Phadia,
Uppsala, Sweden).18 Children were considered seroatopic if
they had a specific IgE 0.35 IU/mL to any of the indoor
allergens tested. Endotoxin was measured in bedroom floor
dust collected at age 1 or 3 years.14
Statistical analyses
Total gas and particle PAH levels were analyzed as the sum
of eight individual PAH as described.9 PAH levels also were
analyzed as the sum of individual PAH with the exclusion of
chrysene, an ETS-derived PAH. Because airborne pyrene
levels were not well-correlated to the other 8 PAH
measured, pyrene levels were analyzed in separate models.
Total sum of 8 PAH, individual PAH measures and IgE
concentrations were natural log transformed due to non-
normal distribution.
Maternal education, dichotomized on completion of high
school at the time of the child’s birth, was used as a proxy
for socioeconomic status. From the BRQ questionnaire,
report of the number of emergency room (ER) visits due to
asthma, wheezing, cough bronchitis or other breathing
problems was dichotomized as zero versus any ER visits. To
reduce the number of tests performed and to increasesample size, age 5 and age 6 respiratory data were
combined and a positive outcome was defined as report of
that outcome at either age 5 or age 6 years. Chi-square
tests were run to test the association between report of
symptoms at age 5 or age 6 years.
Respiratory and specific IgE outcomes were analyzed
using logistic regression models. Total IgE levels were
analyzed using a linear regression model. Data were
analyzed using SPSS Version 17 (Chicago, IL). Interactions
between individual PAH and report of prenatal ETS and
postnatal ETS also were analyzed by logistic regression. All
logistic regression models included maternal education,
maternal asthma, race/ethnicity and sex as covariates.
Results
The demographic characteristics of the cohort are
summarized in Table 1. Results for the interaction between
prenatal PAH and prenatal ETS exposure, as well as main
effects of prenatal and postnatal PAH and ETS exposure,
are presented in Table 2. A significant interaction between
prenatal PAH levels and report of prenatal ETS exposure on
asthma at age 5 or 6 years was found (p Z 0.02). The
interaction approached significance for report of any visit
to the emergency room due to breathing problems at age 5
or 6 years (Table 2). Despite the strong association between
Table 2 Association of PAH and ETS exposure with wheeze and asthma, at age 5 or 6 years.
Total sample main effect Model with addition of prenatal
PAH*prenatal ETS interaction term
OR (95% CI) p-value for interaction
Doctor diagnosed asthma
Prenatal PAH 0.88 (0.63e1.24) 0.020
Prenatal ETS 0.84 (0.44e1.61)
Postnatal PAH 0.83 (0.60e1.15)
Postnatal ETS 0.98 (0.53e1.84)
Current wheeze
Prenatal PAH 1.04 (0.74e1.45) 0.562
Prenatal ETS 1.19 (0.63e2.28)
Postnatal PAH 0.72 (0.52e1.01)
Postnatal ETS 1.26 (0.67e2.34)
Asthma medication use
Prenatal PAH 1.12 (0.80e1.56) 0.323
Prenatal ETS 1.06 (0.55e2.04)
Postnatal PAH 0.66 (0.46e0.93)*
Postnatal ETS 1.09 (0.58e2.05)
ER visits
Prenatal PAH 0.77 (0.53e1.12) 0.083
Prenatal ETS 0.82 (0.42e1.62)
Postnatal PAH 0.75 (0.53e1.07)
Postnatal ETS 0.99 (0.52e1.89)
Nighttime wheeze
Prenatal PAH 1.02 (0.71e1.49) 0.152
Prenatal ETS 1.20 (0.59e2.46)
Postnatal PAH 0.78 (0.53e1.12)
Postnatal ETS 0.80 (0.40e1.60)
Models controlling for maternal asthma, maternal education, race/ethnicity and sex. Prenatal PAH refers to measurements collected
from personal air monitor during the third trimester of pregnancy. Postnatal PAH refers to measurements collected from residential air
monitor when child was aged 5e6 years old. Postnatal ETS is any reported ETS exposure from birth to age 5. Doctor diagnosed asthma,
current wheeze, asthma medication, ER visits, nighttime symptoms as defined in Table 1. *p-value<0.05.
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years, 3 years and 5 years), similar interactions were not
replicated when examining the effects of exposure to
prenatal PAH and postnatal ETS on any respiratory
outcomes at age 5 or 6 years. Also, these results were not
replicated when the sum of 8 PAH was replaced by pyrene
in the model.
To determine the direction of these interactions, the
adjusted models were stratified by the presence or absence
of prenatal ETS exposure. Among those exposed to ETS
prenatally, a nonsignificant positive association with
prenatal PAH exposure was detected for reported asthma at
age 5 or 6 years (OR 1.96, 95% CI [0.95e4.05]). Among those
not exposed to ETS prenatally, a nonsignificant negative
association with prenatal PAH exposure was detected for
asthma (OR 0.65 95% CI [0.41e1.01]).
In main effects analyses, prenatal exposure to PAH was
not significantly associated with report of asthma or any of
the asthma symptoms under study (p > 0.05 in all analyses,
Table 2). Report of prenatal and postnatal ETS was not
associated significantly with any of the respiratory outcomestested. Postnatal PAH exposure was associated negatively
with report of asthma medication use. Logistic regression
models that included endotoxin exposure as a covariate also
did not reveal significant differences in the associations with
respiratory symptoms (results not shown). The same results
were also obtainedwhen chrysene (i.e. PAH indicator of ETS)
was included and excluded from the sum of PAH logistic
regression models (results not shown).
In order to determine whether the interactions or main
effects may be differentially attributable to exposure to
individual PAH, logistic regression models were run sepa-
rately with each of the eight individual prenatal PAHs and
prenatal ETS. Significant differences in the associations
across individual PAH were not detected (Table e1, online
supplement).
Both early PAH and ETS exposures have been associated
individually with the development of seroatopy.19,20 To
determine whether combined exposure to these pollutants
was associatedwith seroatopy in the CCCEH cohort, prenatal
PAH levels and report of ETS exposure were compared to
total and specific IgE production at age 5 years. Postnatal ETS
Prenatal exposure to polycyclic aromatic hydrocarbons 873was associated with greater odds of positive anti-mouse IgE
(OR 5.29, 95% CI [1.58e17.71]). In contrast, prenatal PAH
exposure was associated negatively with anti-d. farinae IgE
(OR 0.23, 95% CI [0.09e0.62]). Significant interactions
between prenatal PAH and prenatal ETS on total and specific
IgE levels were absent.Discussion
These results suggesta significantpositive interactionbetween
prenatal PAH and prenatal ETS on report of asthma at ages 5 or
6 years, even after controlling for current exposures. Prenatal
PAH exposure alone was not associated with asthma or IgE at
age 5 or 6 years. We suspect that the absence of a significant
association of prenatal PAH exposure with asthma symptoms
among children stratified by parents that reported the pres-
ence or absence of prenatal ETS exposure may be due to
diminished statistical power. To our knowledge, this is the first
study to compare prospectively the effects of prenatal PAH,
and its interaction with residential ETS, after controlling for
current exposure, on the subsequent report of asthma.
Growing literature both from experimental studies as well
as epidemiological work suggests that the prenatal period is
a timewhen lungs andotherorgansareparticularly vulnerable
to environmental hazards from exposure to not only PAH and
ETS, but also ozone, nitrogen dioxide, carbon monoxide, and
particulate matter (PM).10,21e26 In the case of ETS, exposure
to prenatal and early postnatal, but not later postnatal side-
stream cigarette smoke, has been shown to increase airway
hyperresponsiveness in mice.21 The National Health and
Nutrition Examination Survey (NHANES) clearly identified the
risk of prenatal ETS on early wheeze, asthma and chronic
bronchitis.27 In a Polish cohort, children exposed to high PAH
levels prenatally had significant higher risks of wheeze, sore
throat, cough and barking cough during the first year of life.10
Murine studies have shown that mice exposed to diesel
exhaust particles (DEP) and PM during pregnancy produce
offspring with greater airway allergic inflammation and
ozone-induced airway hyperresponsiveness.22,28 Prenatal
exposure to PM10, nitrogen dioxide and carbon monoxide also
has been associated with decreased pulmonary lung function
measures in asthmatics.29 Several plausible mechanisms may
explain these associations. Both PAH and ETS exposures have
been associated experimentally with the induction of proin-
flammatory mediators. Cigarette smoke has been shown to
induce mitochondrial production of reactive oxygen species
(ROS) in human bronchial epithelial cells, and inhibit vascular
endothelial growth factor receptor 2 (VEGFR-2), leading to
endothelial cell airway dysfunction, decreased levels of
eNOS, cell migration, and angiogenesis.30,31 ROS can induce
airway hyperresponsiveness and inflammation, two hallmarks
of asthma,while endothelial airway dysfunction also has been
implicated in the pathogenesis of airway disease.32,33
While synergistic effects of combined PAH and ETS expo-
sures have not been demonstrated in the past, other models
of exposure to air pollution suggest such a paradigm is plau-
sible biologically. These include studies suggesting that
rhinovirus infection interacts with the pollutants nitrogen
dioxide and ozone to result in enhanced interleukin(IL)-8
release in human epithelial cells.34 Influenza also has been
shown to modify the association between ozone exposureand hospitalizations for respiratory disease.35 Murine studies
have shown increased ozone-induced airway hyper-
responsiveness in offspring whose mothers were exposed to
particulate matter during pregnancy.22 Parental stress also
has been shown to interact with exposure to traffic-related
air pollution (i.e. NOx) on asthma in humans.
36 Dog ownership
(as a proxy for endotoxin exposure) has been associated with
worse respiratory symptoms when occurring with greater
exposure to air pollutants such as nitrogen dioxide, PM10,
PM2.5 and ozone.
37
In this study, we found one significant interaction between
prenatal PAH and prenatal ETS exposure on the outcome of
doctordiagnosedasthmaatages5or6years.Also, for children
exposed toETS theoddsofdoctordiagnosedasthma increased
with higher prenatal PAH exposure while the association was
negative among the children who were not exposed to ETS
prenatally. The interaction with prenatal ETS, and not post-
natal ETS, differs fromour previous report on the outcomes of
cough and wheeze at age 1 year and difficulty breathing and
probable asthma at age 2 years.9 However, in those analyses,
only the interaction between prenatal PAH and postnatal ETS
was examined, because virtually all mothers who reported
prenatal ETS also reported postnatal ETS. In these current
analyses, even though all ETS measures were correlated,
there was not the same overlap permitting further investiga-
tion. Further, this study was able to control for the effects of
postnatal PAHexposure onwheeze. These newer findingsmay
reflect the true biological effect of the timing of ETS exposure
on the different outcomes under investigation between
studies (i.e. early wheeze9 vs. later or persistent wheeze).
This hypothesis also is supported by a recent Polish study that
found prenatal exposure to PAH, measured as PAH-DNA
adducts, to be associated onlywith onsetwheeze in the first 2
years of life, but not at age 3 or 4 years.38
Prenatal PAH exposure alone was not associated with
persistent wheeze and asthma at ages 5 or 6 years. There are
several reasons why we may have failed to find these associ-
ations. First, theremay be no effect of prenatal PAHexposure
onpersistentasthma,or theeffectmaybesosmall thatweare
insufficiently powered to detect it. Also, there may be other
unmeasured environmental exposures that may be more
important to the development of asthma than PAH. Another
possibility is that the association between prenatal PAH
exposure and respiratory health may be dependent on the
timing of exposurewithin gestation. A recent study by Herr et
al. showed that the association between prenatal PAH expo-
sure onelevated cordblood IgE varied by gestationalmonth of
exposure.39 PAH exposure during the first two months of
pregnancy was associated with lower cord blood IgE; higher
PAH exposure during the fourth through seventh month of
pregnancy with elevated cord blood IgE. In our study, all the
prenatal monitoring was done during the third trimester
limiting such an analysis. During the third trimester, when
most (∼80%) of the prenatal monitoring was conducted in this
study, Herr et al. did not observe significant associations
between PAH levels and cord blood IgE.
Arguably, the association between prenatal PAH and
asthma trends in the negative direction, though without
statistical significance. Our analyses also showed a signifi-
cant negative association between postnatal PAH exposure
and the report of asthma medication use, but not current
wheeze or ER visits due to respiratory problems, making
874 M.J. Rosa et al.these results difficult to interpret. However, there are
plausible mechanisms through which these exposures may
be associated with decreased airway inflammation. PAH
have been shown to induce thymus atrophy and thymocyte
apoptosis in a murine model, and have been implicated in
the suppression of human T cell mitogenesis.40,41 Also,
there is evidence that PAH exposure can inhibit B cell
growth and/or induce pre-B cell apoptosis.42,43 This latter
process may downregulate IgE and other Ig production and
these mechanisms could be associated with a decrease in
respiratory symptoms.
Genetic variation also has been shown to modify the
effect of exposure to pollutants on respiratory outcomes.
Previous work has been done on the family of detoxification
enzymes, the glutathione S-transferase (GST) genes and
tobacco smoke exposure. Breton et al. reported a signifi-
cant interaction between prenatal tobacco smoke exposure
and the GSTM2 gene on lung function outcomes in children.
In this study, a significant decrease in lung function was
detected among children whose mothers smoked during
pregnancy and possessed the GSTM2 risk haplotype.44
Conversely, the null haplotype had a protective effect in
the exposed children.44 Also, a study in Germany reported
that children with ETS exposure and GSTM1 deficiency had
higher odds of current asthma and asthma symptoms than
GSTM1 positive children without ETS exposure.45 Another
recent study also showed that the lack of GSTM1 was
associated with a decrease in lung function and early onset
asthma among children exposed to prenatal ETS.46
We hypothesized that combined prenatal PAH and ETS
exposure may be associated with higher IgE levels among
children participating in the CCCEH cohort because both
PAH47e51 and ETS20,52,53 exposures have been associated
with the production of T helper (Th) proallergic cytokines
or allergic sensitization. In this study, the results were
mixed. Postnatal ETS was associated with greater odds of
positive anti-mouse IgE while prenatal PAH exposure was
associated negatively with anti-cockroach and anti-d.
farinae IgE. The latter finding may be consistent with our
previous findings in mice where combined prenatal expo-
sure to diesel and the mold allergen Aspergillus fumigatus
was associated with decreased total IgE in the offspring.54
Indeed, the effect of traffic-related air pollution on IgE
appears to vary according to the specific allergen. For
example, the PIAMA study found that exposure to PM2.5,
soot and nitrogen dioxide was associated with sensitization
to food allergens, but not with sensitization to house dust
mite, cat, dog, Dactylium, birch pollen or Alternaria.55
We acknowledge several limitations in the study. While
the power was sufficient to detect some PAH by ETS inter-
actions, the statistical power of the stratified analyses was
more limited. In order to find statistically significant results
with 80% power among these strata, we would need 424
children with prenatal ETS exposure and 1120 children
without prenatal ETS exposure, an expensive study beyond
the scope of this large cohort study. Therefore, the stratified
results should be interpreted with caution. Also, exposure to
ETS used in the final analyses was assessed using question-
naires. However, plasma cotinine levels were associated
significantly with report of ETS exposure at every age
measured, in agreement with our previously published
results.56 Because methods that rely on self-report tend tounderreport ETS exposure, any bias would lead to an
underestimation of the effects of ETS. Cotinine is also
a marker of short term (past 48 h) ETS exposure and may not
adequately capture recurrent exposure throughout preg-
nancy.57,58 Further, the significant ETS-derived PAH contri-
butions, i.e. chrysene, to the total PAH concentrations that
were measured cannot be discounted. However, removal of
chrysene from the regression models did not change the
associations significantly suggesting otherwise.
Another caveat is the difficulty in separating measures of
prenatal ETS exposure from postnatal ETS exposure given
their strong association (the report of presence or absence
of prenatal ETS exposure was the same for 78% of the
participants at age 6 months, 82% at age 1 year, 74% at age 2
years, 72% at age 3 years and 74% at 5 years, all c2 p-values
<0.001 for comparisons). However, significant interactions
between postnatal ETS and prenatal PAH exposure on age 5
or 6 asthma-related outcomes were not detected. Finally,
the postnatal PAH analyses relied on indoor measurements
that may be more representative of indoor rather than
traffic-related PAH sources. Outdoor PAH concentrations
may represent more accurately the child’s personal expo-
sure to traffic-related air pollution. However, previously
reported comparisons between indoor and outdoor sampling
has shown that several of the PAHs measured indoors are
derived primarily from outdoor sources; in particular the
higher molecular weight, nonvolatile PAHs.15
In conclusion, a significant interaction between prenatal
exposures to PAHs and ETS on reported asthma at age 5 or 6
years was detected. There were no significant associations
between prenatal PAH exposure and respiratory symptoms or
seroatopy at age 5 or 6 years. Further study is required to
understand the effect modification of ETS exposure on the
association between PAH exposure and respiratory outcomes.
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